Paj 1 soti nan 20 rezilta yo
FIELD OF THE INVENTION
The invention relates generally to the field of treatment of invasive agents, such as pathogens and cancers, in living organisms such as the human body and, more particularly, to a system that applies an energy field to the living organism, to activate particles which are
FIELD OF THE INVENTION
The invention relates generally to the field of treatment of invasive agents, such as pathogens and cancers, in living organisms such as the human body and, more particularly, to a system that generates an energy field for application to the living organism, to activate
FIELD
Provided herein are methods for treating cancer, specifically urinary tract cancer, by way of at least one cell cycle regulator, and at least one anti-cancer drug for local treatment; wherein the therapeutic agents are embedded in, and slowly released from, a biocompatible hydrogel
FIELD OF THE INVENTION
The invention relates to dental and oral prophylactics and, more specifically, to dentifrices such as toothpastes and oral washes which exhibit medicinal, prophylactic, and hygienic effects. In particular, a composition for a dentifrice toothpaste containing calcium sulfate
BACKGROUND OF THE INVENTION
The present invention relates to treatment of cancer, and more particularly to a cancer treatment system delivering thermal energy from a body cavity to a cancerous volume of tissue while supplementing the effects of the thermal therapy with a complementary treatment
FIELD OF THE INVENTION
The invention relates to the use of imino acid conjugates of methylglyoxal for the inhibition and/or treatment of cancer. The invention relates more specifically to the use imino acid conjugates of methylglyoxal for inhibition and/or treatment of cancer of the Colon, Prostate,
FIELD OF INVENTION
The invention relates to the use of novel anthracene based compounds for the inhibition or prevention of the growth or multiplication of cancer cells, and to therapeutic compositions containing such compounds. The invention relates more specifically to the use of hydroanthracene
FIELD OF THE INVENTION
This invention is directed to an in situ-formed bioactive tissue adherent compliant film produced by spraying a methyl acetate solution of an absorbable crystallizable polymer containing at least one soluble or microdispersed bioactive agent. Depending on the application site,
CROSS-REFERENCE TO RELATED APPLICATION
The present application claims priority to provisional application U.S. Ser. No. 61/337,295, filed Feb. 2, 2010.
FIELD OF THE INVENTION
This invention is directed to an in situ-formed bioactive tissue adherent compliant film produced by spraying a methyl
FIELD OF THE INVENTION
This invention is directed to an in situ film-forming methyl acetate-based solution of an absorbable segmented block copolymer with amorphous and semi-crystalline segments containing at least one soluble or microdispersed bioactive agent. Depending on the application site, the
FIELD OF THE INVENTION
The present invention relates to the treatment of cancer, and particularly relates to the treatment of cystic brain tumors and cystic brain tumor resection cavities with anti-tenascin antibodies such as 81C6.
BACKGROUND OF THE INVENTION
Despite years of intensive
CROSS REFERENCE TO RELATED APPLICATIONS
This application is the U.S. national phase of International Application No. PCT/GB2003/004950 filed on Nov. 13, 2003 and published in English on May 27, 2004 as International Publication No. WO 2004/044950, which application claims priority to GB Patent
FIELD OF THE INVENTION
The technology relates generally to the focused delivery of therapy such as phytotherapy, cryosurgery, thermotherapy, radiation therapy, and chemotherapy to regions of diseased tissue as exemplified by devices for brachytherapy and methods of using and making such devices.
The
II. FIELD OF THE INVENTION
This application relates to apparatus and methods for noninvasive monitoring of cancerous cells in intracorporeal fluid accumulations.
III. BACKGROUND OF THE INVENTION
Certain cancers can result in pathologic chronic collection of bodily fluids within cavities such as the
FIELD OF THE INVENTION
This invention deals with fiber-reinforced composite systems comprising an absorbable fiber and a partially or essentially non-absorbable matrix for use in the controlled release of one or more bioactive agent(s) at the desired biological site, which may entail intravaginal,